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Background: Parkinson’s disease (PD) is a neurological disorder resulting from the 
progressive loss of dopaminergic neurons. There is currently no known cure for PD, thus the 
search for complementary and alternative medicines capable of halting the degeneration of 
dopaminergic neurons is plausible. Carpobrotus edulis (CE) is an indigenous plant used in 
South African traditional medicine used for the treatment of a number of disease conditions 
including tuberculosis, diabetes mellitus and constipation. It has been suggested that CE 
contains bioactive compounds which are responsible for its acclaimed medicinal potential. No 
studies have been reported on the potential benefit of CE to the nervous system. This study 
was therefore done to evaluate the protective effects of CE against 1-methyl-4-
phenylpyridinium (MPP+)-induced toxicity in the dopaminergic SH-SY5Y cell line, as well as 
its underlying mechanism. Methods: In this study, SH-SY5Y cells were treated with varying 
concentrations of CE and MPP+ respectively to determine the optimal concentrations of MPP+ 
and CE for further experiments. Thereafter, SH-SY5Y cells were pre-treated with 30 μM of 
CE before exposure to 2 mM of MPP+ to induce cellular damage. Cell viability was evaluated 
using the MTT assay, intracellular reactive oxygen species (ROS) production was determined 
using flow cytometry and the Hoechst nuclear staining was used to visualize apoptosis. 
Caspases 3/7 and 9 activity was assessed using commercially available kits. Results: MPP+ 
treatment induced marked cell viability, increased the number of condensed nuclei and 
apoptotic cells, increased ROS production, initiated caspase 9 and activated caspase 3/7 in SH-
SY5Y cells. The observed effects of MPP+-induced toxicity were attenuated by the pre-
treatment of SH-SY5Y cells with 30 μM of CE. Conclusion: The protective effects of CE 
against MPP+-induced toxicity in SH-SY5Y cells may be attributed to its antioxidant and anti-
apoptotic properties. 
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INTRODUCTION   
Parkinson’s disease (PD) is a common 
neurodegenerative disorder characterized by the 
progressive loss of dopaminergic neurons in the pars 
compacta part of the substantia nigra (SNpc) of the 
midbrain. Its clinical motor symptoms include muscle 
rigidity, bradykinesia and tremor, while non-motor 
symptoms include a variety of neuropsychiatric 
disorders (Magrinelli et al., 2016, Sveinbjornsdottir, 
2016). Presently, there is no cure for PD (Hu et al., 
2010),  as      such   drug  treatments     like L-dopa and   
 
carbidopa are only able to alleviate PD symptoms but 
are unable to halt the degeneration of dopamine 
neurons or stop the advancement of the disease 
(Connolly and Lang, 2014). Consequently, the search 
for new PD therapies has led to widespread research 
into complementary and alternative medicines of 
therapeutic value (Doo et al., 2010).  
Previous studies have reported the beneficial effects of 
herbal medicines in preventing dopaminergic neuronal 
degeneration (Iriti et al., 2010), and the World Health 
Organization is currently encouraging research on the 
identification and valorisation of medicinal plants, 
which are known to be important sources of molecules 
and/or products in traditional and modern medicine 
(Rocha et al., 2017). In this regard, herbal plants and 
their phytochemicals have been proposed as novel 
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neuroprotective treatments for several 
neurodegenerative disorders. A notable plant in this 
regard is Carpobrotus edulis (CE), an edible medicinal 
plant native to the coast of South Africa (Rocha et al., 
2017). CE is known by the name Igcukuma among the 
Xhosa communities of South Africa and is commonly 
used by the traditional healers to treat diabetes mellitus, 
constipation, sores, elevated blood pressure, 
tuberculosis and intestinal worms (Omoruyi et al., 
2012). This plant is widely reported to exhibit several 
biological activities including antioxidant, immune-
modulating, antimicrobial; anticholinesterase and 
antitumoural effects (Martins et al., 2010, Martins et 
al., 2011, Custódio et al., 2012, Omoruyi et al., 2012). 
The bioactive molecules already isolated from CE 
include rutin, oleanolic acid and cactichin (van der 
Watt and Pretorius, 2001, Martins et al., 2010, Martins 
et al., 2011). 
Cellular neuronal model systems have long been 
utilized to investigate the mechanisms of 
neurodegeneration and for the identification of novel 
neuroprotective agents in PD. In the present study, the 
human SH-SY5Y neuroblastoma cell line was used 
based on its reported ability to express tyrosine 
hydroxylase and to display adequate dopamine-β-
hydroxylase activity, which is a peculiar charateristic of 
dopaminergic neurons (Ross et al., 1983). In addition, 
the SH-SY5Y cells are known to exhibit some 
properties of stem cells and to express the dopamine 
transporter, DAT, which is responsible for the control 
of dopamine equilibrium via precise uptake and 
sequestration of dopamine (Takahashi et al., 1994). 
DAT is the access point for such neurotoxins as 6-
hydroxydopamine (6-OHDA) and 1-methyl-4-
phenylpyridinium (MPP+) into neurons, consequently 
making SH-SY5Y cells an appropriate model for 
studies utilizing toxin-induced PD.  
MPP+ has been widely utilized as a neurotoxin to 
investigate PD mechanisms owing to its selective 
toxicity to dopaminergic neurons (Nakamura et al., 
2000). In astrocytes, the neurotoxin 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine (MPTP) is oxidized by 
monoamine oxidase (MAO)-B into its active 
metabolite, MPP+ which is then transported into the 
dopaminergic neurons via the DAT to accumulate in 
mitochondria. Here, MPP+ effectively inhibits complex-
1 of the electron transport chain to trigger a condition 
that is similar to PD in experimental models (Singer 
and Ramsay, 1990, Przedborski and Jackson-Lewis, 
1998). Evidence in literature suggests that MPP+-
triggered cell death involves multiple mechanisms 
(Soldner et al., 1999, Nakamura et al., 2000). For 
example, MPP+ is reported to produce an increase in 
reactive oxygen species (ROS) and oxidative damage in 
various PD models (Cassarino et al., 1997). Also, 
studies on animal models of PD showed that MPP+-
induced oxidative damage was inhibited by the 
overexpression of antioxidant enzymes, while another 
study showed that antioxidant molecules attenuated 
MPP+ toxicity in in vitro PD models (Przedborski et al., 
1992, Lai et al., 1993). In the same light, MPP+-
triggered cell death has been found to exhibit features 
of apoptosis (Marini et al., 1989, Dipasquale et al., 
1991). Although MPP+-induced apoptotic cell death is 
mediated by the initiation of caspase 9 and 8, as well as 
the activation of caspase 3, it is attenuated by the 
caspase inhibitors (Marini et al., 1989). Therefore, this 
study aims to evaluate the neuroprotective activity of 
CE against MPP+-induced oxidative damage and 
apoptosis in SH-SY5Y neuroblastoma cells. 
 
METHODS 
Preparation of extract 
Small twigs of CE were obtained from the University 
of the Western Cape nature reserve, air-dried at room 
temperature and the dried plant parts then reduced to 
powder and extracted overnight with 1 litre of de-
ionized boiling water. The resultant extract was then 
filtered and freeze-dried to give a powdered aqueous 
extract.  
 
Cell culture maintenance 
SH-SY5Y neuroblastoma cells, generously donated by 
Dr AM Serafin (Division of Radiobiology, 
Stellenbosch University, South Africa), were 
maintained in Dulbecco’s modified Eagle medium 
(DMEM) (Life Technologies, USA), supplemented 
with 10% Fetal bovine serum (FBS) (Life 
Technologies, USA) and 1% penicillin-streptomycin 
(Lonza, USA), at 37°C and 5% CO2 in a humidified 
incubator. The culture media was replaced every 2-3 
days and cells were trypsinized (1X trypsin-versene 
EDTA mixture, Lonza, USA) and transferred to another 
dish for regrowth once it attained confluency 
of approximately 70-80%. 
 
Cytotoxicity screening  
To ensure that SH-SY5Y cells were exposed to the 
right concentration of MPP+ and CE for the appropriate 
exposure duration, cytotoxicity screening was 
performed using the MTT assay. A fresh 50mM stock 
concentration of MPP+ was prepared in un-
supplemented DMEM, and dilutions were made in 
culture medium for final concentrations ranging 
between 0 and 5000 μM. To evaluate the 
neuroprotective effects of CE, a fresh 5 mg/ml stock 
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concentration of the extract was prepared in 1X 
Phosphate buffered saline solution (PBS, Lonza, USA) 
and dilutions were made up in culture media for final 
concentrations ranging between 0 and 50 μg.  
 
Evaluation of cell viability 
Cell viability was determined using the MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, 
St. Louis, MO, USA) assay, which indicates the 
functional integrity of the mitochondria and of cellular 
viability (Slater et al., 1963, Van de Loosdrecht et al., 
1994). SH-SY5Y cells were seeded at a density of 1.0 x 
104 cells/well in 96-well plates and were allowed to 
attach for 24 hours. Cells were thereafter pre-treated 
with complete culture media supplemented with 30 μM 
concentrations of CE for 1 hour and then treated with 2 
mM of MPP+ for 24 hours. These concentrations and 
exposure durations were selected based on findings 
from prior cytotoxicity screening. After treatment, 20μl 
of the MTT solution was added to each well of the 96-
well plate for 4 hours, and the Glomax Multi Detection 
System (Promega, USA) was used to detect the 
absorbance at a wavelength of 560nm. 
 
Evaluation of cell morphology 
SH-SY5Y cells were seeded at a density of 1.1 x 105/ml 
in 60 mm dishes and allowed to attach for 24 hours 
after which the cells were treated as previously 
described and cell morphology was done using a ZEISS 
Primo Vert (Germany) light microscope. 
 
Nuclear staining with Hoechst 
Hoechst 33342 nucleic acid stain (Life Technologies, 
USA) was used to demonstrate apoptosis in the treated 
samples. SH-SY5Y cells were seeded at a density of 
1.1 x 105 /ml in 60mm dishes and were allowed to 
attach for 24 hours under standard incubation 
conditions. After treatment, experiments were 
performed according to the manufacturer’s instructions 
and 20µl of cells in the staining solution was placed on 
a glass slide, followed by cover-slipping and viewing 
with a Zeiss Axio-plan 2 fluorescent microscope (Zeiss, 
Germany). 
 
Evaluation of Caspase 9 activity 
The ApoTarget™ Caspase-9 Protease Assay (Life 
Technologies, USA) kit was used to evaluate the 
activity of caspase-9 in treated and untreated SH-SY5Y 
cells seeded at a density of 1.2 x 105 /ml in 100mm 
dishes. The cells were allowed to attach for 24 hours 
after treatment, and adherent cells were displaced with 
a cell scraper, transferred to a tube on ice, pelleted in 
ice-cold PBS at 3000 rounds per minute (rpm) for 5 
minutes, re-suspended in 50μL of chilled cell lysis 
buffer and incubated on ice for 10 minutes. 
Experiments were performed according to the 
manufacturer’s instructions, and absorbance was 
detected using a Polarstar Omega plate reader (BMG 
Labtech, USA) at 405nm. 
 
Evaluation of Caspase 3/7 activity 
The Caspase 3/7 assay kit (Promega, USA) was used to 
determine the activity of caspase 3/7 in treated and 
untreated samples. SH-SY5Y cells were seeded at a 
density of 10000 cells/well in white-walled 96-well 
plates and allowed to attach for 24 hours. After 
treatment, subsequent experiments were performed 
according to the manufacturer’s instructions, and 
luminescence was detected using the Glomax Multi 
Detection System. 
 
Evaluation of reactive oxygen species 
The reagent 2′,7′-Dichlorofluorescin diacetate (DCFH-
DA, St. Louis, MO, USA) was used to evaluate 
intracellular ROS production in SH-SY5Y cells seeded 
at a density of 1.2 x 105 /ml in 100mm dishes. Cells 
were allowed to attach for 24 hours under standard 
incubation conditions and after treatment, adherent 
cells were displaced with a cell scraper, spun down 
using a Bio-Rad table top centrifuge at 3000 rpm for 5 
minutes, and cell pellets were resuspended and 
incubated with DMEM containing 25 μM of DCFH-
DA for 45mins. Afterwards, cells were centrifuged for 
5 minutes at 3000 rpm, and the pellets were re-
suspended in 500μl PBS. Stained cells were acquired 
and analysed on an Accuri flow cytometer (BD 
Biosciences Pharmingen, San Diego, CA, USA) and a 
total of 10000 events were collected for each sample. 
 
Statistical analysis 
GraphPad Prism Software V7 was used for all 
statistical analyses (www.graphpad.com/scientific-
software/prism/) and data was expressed as means with 
standard error of mean (SEM) from three independent 
experiments. One-way analysis of variance (ANOVA), 
followed by Tukey's multiple comparisons post-hoc test 
was performed to analyze the relationship between 
variables. Level of statistical significance was 
considered at p < 0.05. 
 
RESULTS 
Dose-response of MPP+ and CE toxicity 
In order to determine the concentration of MPP+ that 
induced approximately 50% cell death in the SH-SY5Y 
cells, increasing concentrations of MPP+ (1000 µM – 
5000 µM) were added to the cells and allowed to  
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Fig. 1: Cytotoxicity screening in SH-SY5Y cells. (A) MPP+ and (B) CE. *p < 0.0001 vs untreated SH-SY5Y cells. 
 
 
incubate for 24 hours. Results obtained show 
significant decrease (p < 0.0001, Figure 1A) in cell 
viability which was concentration-dependent. 
Approximately 50% cell death occurred at the MPP+ 
concentration of 2000 µM and this concentration was 
chosen for use in further experiments. On the other 
hand, exposure of SH-SY5Y cells to increasing 
concentrations of CE (10 µg - 50 µg) showed no 
effect on cell viability after 24 hours incubation. 
Based on the highest absorbance value, a 
concentration of 30 μg of CE (p = 0.9734, Figure 1B) 
was chosen for further experiments. 
 
CE inhibits MPP+-induced reduction in cell viability  
To investigate the protective activity of CE, cells 
were pre-treated with CE before being exposed to 
MPP+. Results showed that whereas treatment with 
MPP+ significantly decreased cell viability (P = 
0.0001), pre-treatment with CE significantly 
improved (p = 0.0024, Figure 2) cell viability. Also, 
there was no significant difference (p > 0.05) 
following treatment of SH-SY5Y cells with CE only.  
 
CE prevents MPP+-induced changes in morphology 
Following visualisation of SH-SY5Y cells under the 
light microscope, morphological changes linked to 
cell death in MPP+-treated SH-SY5Y cells, were 
observed including cell contraction/shrinkage and 
rounding up of cell bodies. Pre-treatment with CE 
however, significantly inhibited the morphological 
alterations induced by MPP+, and the morphology of 
cells exposed to CE only, was similar to that of the 
untreated cells (Figures 3A and 3D respectively). 
F
Fig. 2: CE protects cell viability in MPP+-treated SH-SY5Y 
cells P < 0.0005 vs untreated SH-SY5Y cells; *p < 0.005 
vs SH-SY5Y cells treated with MPP+ only.  
 
 
Fig. 3: Morphological changes in SH-SY5Y cells. (A) 
Untreated SH-SY5Y cells (B) SH-SY5Y cells treated with 
MPP+ only (C) SH-SY5Y cells pre-treated with CE and then 
treated with MPP+ (D) SH-SY5Y cells treated with CE only. 
Arrows indicate degenerating and shrinking SH-SY5Y cells. 
Scale bar: 5 μm. 
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Fig. 4: CE inhibits accumulation of ROS following MPP+ toxicity. SH-SY5Y cells treated with MPP+ only vs (A) untreated 
(B) CE pre-treated (C) untreated vs CE (D) ROS production in SH-SY5Y cells. Arrows indicate intensity of cells treated with 
MPP+ only. p < 0.0001 vs untreated SH-SY5Y cells; *p < 0.05 vs SH-SY5Y cells treated with MPP+ only. 
 
 
CE mitigates MPP+-induced overproduction of ROS 
Reports indicate that excessive production of ROS is a 
principal mechanism for MPP+-induced apoptosis and 
cell death (Pariyar et al., 2017). CE mitigates MPP+-
induced overproduction of ROS 
Reports indicate that excessive production of ROS is a 
principal mechanism for MPP+-induced apoptosis and 
cell death (Pariyar et al., 2017). Accordingly, the 
possible involvement of antioxidant mechanisms in the 
protective activity of CE against MPP+-induced toxicity 
was investigated. Results showed that exposure to 
MPP+ significantly increased (p < 0.0001, Figure 4) 
intracellular ROS levels in SH-SY5Y cells, and pre-
treatment with the selected CE concentration 
significantly (p = 0.0376) mitigated MPP+-induced 
accumulation of intracellular ROS. Treatment of SH-
SY5Y cells with CE only did not significantly (p > 
0.05) alter intracellular ROS levels when compared to 
the untreated cells (Figure 4D). 
 
CE inhibits MPP+-induced apoptosis in SH-SY5Y 
cells 
To further examine the protective effects of CE on 
MPP+-induced toxicity, morphological changes in cell 
nuclei were investigated in the presence or absence of 
CE using the Hoechst 33342 nucleic acid stain. Results 
showed that the cells undergoing apoptosis (a form of 
cell death) in the MPP+-treated alone group had more 
condensed nuclei when compared to the untreated cells. 
Conversely, in the cells pre-treated with CE, fewer 
condensed nuclei were observed (Figure 5), and no 




Fig. 5: CE inhibits nuclear damage following MPP+ toxicity. 
SH-SY5Y cells were (A) untreated (B) treated with MPP+ 
only (C) pre-treated with CE and then MPP+ (D) treated with 
CE only. Scale Bar: 100 μm 
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Fig. 6: CE inhibits MPP+-induced apoptosis in SH-SY5Y cells. (A) Caspase 9 activity (B) Caspase 3/7 activity. p < 0.005 vs 
untreated SH-SY5Y cells; *p < 0.05 vs SH-SY5Y cells treated with MPP+ only. 
 
 
CE inhibits Caspase 3/7 and 9 activities in SH-
SY5Y cells treated with MPP+  
Apoptosis is moderated through caspases which 
initiate a proteolytic cascade when triggered, 
thereby resulting in cell death (Halonen, 2015). To 
determine the role of caspases in this model of PD, 
the activities of caspase 9 (an initiator caspase) and 
caspase-3/7 (a key executioner of apoptosis) were 
investigated. Results showed that following 
treatment with MPP+ only, there was a significant 
increase in the activities of caspases 9 and 3/7 
respectively, while pre-treatment with CE 
significantly decreased the activity of caspase 9 
and 3/7. Also, there was no significant difference 
(p > 0.05) in the activities of the caspases in cells 
treated with CE only when compared to untreated 
cells. These findings indicate that although 
treatment with CE alone had no significant effects, 
pre-treatment of SH-SY5Y cells with CE protected 
the cells from apoptosis induced by MPP+. 
Apoptosis is moderated through caspases which 
initiate a proteolytic cascade when triggered, 
thereby resulting in cell death (Halonen, 2015). To 
determine the role of caspases in this model of PD, 
the activities of caspase 9 (an initiator caspase) and 
caspase-3/7 (a key executioner of apoptosis) were 
investigated. Results showed that following 
treatment with MPP+ only, there was a significant 
increase in the activities of caspases 9 and 3/7 
respectively, while pre-treatment with CE 
significantly decreased the activity of caspase 9 
and 3/7. Also, there was no significant difference 
(p > 0.05) in the activities of the caspases in cells 
treated with CE only when compared to untreated 
cells. These findings indicate that although 
treatment with CE alone had no significant effects, 
pre-treatment of SH-SY5Y cells with CE protected 
the cells from apoptosis induced by MPP+. 
 
DISCUSSION 
PD is a complex disorder pathologically 
characterized by age-dependent degeneration of 
dopaminergic neurons in the SNpc of the 
midbrain. Several PD models have been utilized 
for the investigation of mechanisms involved in 
PD, however, over the years, MPP+-treated SH-
SY5Y cells have become an important in-vitro 
model for investigating mechanisms of 
neurodegeneration in PD. This study aimed at 
evaluating the neuroprotective activity and 
possible mechanisms of CE on MPP+-induced 
toxicity in SH-SY5Y neuroblastoma cells. In the 
present study, we provided the first evidence that 
CE attenuates MPP+-induced toxicity in SH-SY5Y 
neuroblastoma cells. CE inhibited MPP+-induced 
ROS generation, improved viability, prevented 
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nuclear condensation, inhibited the initiation of 
caspase-9 activity and prevented the activation of 
caspase-3/7. The investigated into the cellular and 
molecular mechanisms responsible for the activity 
of CE have not been previously reported, and our 
findings demonstrate possible mechanisms that 
may underlie the neuroprotective activity of CE. 
One of the possible mechanisms for the 
neuroprotective activity of CE is its antioxidant 
effect. Previous reports demonstrate that the 
oxidative damage occurring in the brains of PD 
patients may be responsible for the degeneration of 
dopaminergic neurons (Lo et al., 2012). Excessive 
production of ROS and an impairment in the 
cellular antioxidant activities lead to oxidative 
stress. It has been reported that excessive ROS is 
produced in the brains of PD patients during 
dopamine metabolism, further aggravated by 
reduced levels of glutathione and increased 
calcium and iron levels in the SNpc (Jenner, 2003). 
Various studies have demonstrated that herbal 
products with antioxidant properties are capable of 
protecting dopaminergic neurons in various toxin-
induced models of PD. For instance, the aqueous 
extract of Panax ginseng was evaluated for its 
protective activity against MPP+-induced 
cytotoxicity in SH-SY5Y cells, and the authors 
reported the inhibition of ROS production as a 
possible mechanism for the protective effects (Hu 
et al., 2011). Similarly, Gastrodia elata extracts 
were found to significantly prevent MPP+-induced 
reduction in viability of SH-SY5Y cells possibly 
through the inhibition of ROS generation (An et 
al., 2010). In another study, the dried root extract 
of Polygala tenuifolia was found to significantly 
mitigate 6-OHDA-induced damage to PC12 cells 
via the amelioration of ROS production and 
caspase-3 activity (Choi et al., 2011). As 
previously mentioned, our findings from this study 
agree with these studies showing that MPP+ 
treatment resulted in a significant increase in ROS 
production (Figure 4), and that CE effectively 
attenuated this effect and thus prevented the 
deleterious effect associated with excessive ROS 
production.  
Caspases play a primary role in the process of 
apoptotic cell death (Markus, 2000); two 
prominent pathways involved in apoptosis include 
the intrinsic or mitochondrial pathway and 
extrinsic or death receptor pathway (Elmore, 
2007). Either of the extrinsic or intrinsic pathways 
activate caspase 8, 9 and 10 (initiator caspases), 
and congregate on caspase 3 to trigger caspase 6 
and 7 (effector caspases), thus leading to apoptosis 
(Halonen, 2015). Caspase-3/7 and 9 have been 
reported to participate in MPP+-induced apoptosis, 
and it is believed that excessive production of ROS 
triggers these activities. In this study, treatment of 
SH-SY5Y cells with MPP+ resulted in an increase 
in the activities of caspase-3/7 and 9 respectively, 
which is in line with previous studies (Kost et al., 
2012, Li et al., 2017). However, pre-treatment with 
CE successfully inhibited MPP+-induced activation 
of caspase-3/7 and 9 (Figure 6). The inhibition of 
MPP+-induced activation of caspase-3/7 by CE 
indicates that it may act to prevent the initiation of 
caspase 9 in order to prevent apoptosis. Also, in 
line with reports in literature on MPP+-induced 
condensation of nuclei (Wang and Xu, 2005, Shen 
et al., 2017), findings from the present study 
showed that CE prevented nuclear condensation 
and further decreased the number of apoptotic cells 
in MPP+-SH-SY5Y cells (Figure 5), thus providing 
additional proof for the anti-apoptotic properties of 
CE. 
In conclusion, the results from the present study 
indicate that CE prevents MPP+-induced toxicity in 
SH-SY5Y neuroblastoma cells. Its antioxidant and 
anti-apoptotic properties render this plant 
potentially protective against the deleterious 
effects of PD. The neuroprotective mechanisms of 
CE observed in this study are possibly as a result 
of the bioactive compounds contained in the plant. 
The bioflavonoid, rutin (already isolated from this 
plant), is reported to be effective in the inhibition 
of 6-OHDA-induced toxicity in animal and cellular 
models of PD (Khan et al., 2012, Magalingam et 
al., 2013). Based on the findings from this study, 
further investigation on the neuroprotective 
mechanisms of CE in other experimental models 
of PD is recommended, to increase the volume of 
evidence on the potential candidacy of this plant 
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